Rare genetic variants influence participation in cognitive components of the UK Biobank
- 1Cardiff University
Abstract
Population-level biobanks are transforming health and genomic research however they are all subject to recruitment and participation biases, the impacts of which are not fully understood. The UK Biobank (UKBB) is one such cohort; it is widely used for health-related research, but its participants are not representative of the UK general population. In addition, those who complete optional components of UKBB differ from those who do not in terms of health-related exposures and outcomes. Participation in UKBB has a partly genetic basis, but the extent to which rare variants influence participation in optional study components, and how this might impact findings of rare variant association studies, is unknown.
We analysed exome sequencing and array data from 398,149 UKBB participants to examine rare variant contributions to UKBB participation bias, focusing on cognitive phenotypes. We found that classes of rare variation previously shown to contribute to cognition were enriched among participants who completed fewer cognitive tests. We then compared the effects of rare variants on cognition itself between groups of participants defined by whether they completed all online cognitive tests. Rare variants had significantly weaker effects on cognition in individuals who completed all online cognitive tests than in those who did not.
These findings demonstrate that participation is a non-random phenotype that is influenced by rare variants, and that individuals who engage in optional UKBB components are not representative of the broader cohort. We show how participation bias can reduce the power of rare variant association studies, potentially masking true associations. This bias should therefore be carefully considered when interpreting results derived from phenotypes with substantial missingness.
Related
- Potential Influence of NUCB2 Genetic Variants on the Clinicopathological Features of Patients with Hepatocellular Carcinoma
- Influence of genetic variants on the response to long-acting β2-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) and combination therapies in patients with chronic obstructive pulmonary disease (COPD): a systematic review
- Comparing the effectiveness of emotion-focused therapy and cognitive rehabilitation based on RehaCom software on emotional and cognitive components in female migraine patients: A randomized control trial.
- How do support networks influence physical activity participation among adults with a learning disability? A scoping review protocol
- Utilizing a Variant Prioritization Approach to Explore Genetic Variants in Cervical Cancer Cases among Malawian Women
BibTeX
@misc{fenner2026rare,
title = {{Rare genetic variants influence participation in cognitive components of the UK Biobank}},
author = {E. Fenner and P. Holmans and M. C. O'Donovan and M. J. Owen and E. Rees and J. T. R. Walters},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.08.26365060},
url = {https://www.medrxiv.org/content/10.64898/2026.10.08.26365060v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Rare genetic variants influence participation in cognitive components of the UK Biobank
AU - E. Fenner
AU - P. Holmans
AU - M. C. O'Donovan
AU - M. J. Owen
AU - E. Rees
AU - J. T. R. Walters
PY - 2026
DA - 2026/10/08
PB - medRxiv
DO - 10.64898/2026.10.08.26365060
UR - https://www.medrxiv.org/content/10.64898/2026.10.08.26365060v1
AB - Population-level biobanks are transforming health and genomic research however they are all subject to recruitment and participation biases, the impacts of which are not fully understood. The UK Biobank (UKBB) is one such cohort; it is widely used for health-related research, but its participants are not representative of the UK general population. In addition, those who complete optional components of UKBB differ from those who do not in terms of health-related exposures and outcomes. Participation in UKBB has a partly genetic basis, but the extent to which rare variants influence participation in optional study components, and how this might impact findings of rare variant association studies, is unknown. We analysed exome sequencing and array data from 398,149 UKBB participants to examine rare variant contributions to UKBB participation bias, focusing on cognitive phenotypes. We found that classes of rare variation previously shown to contribute to cognition were enriched among participants who completed fewer cognitive tests. We then compared the effects of rare variants on cognition itself between groups of participants defined by whether they completed all online cognitive tests. Rare variants had significantly weaker effects on cognition in individuals who completed all online cognitive tests than in those who did not. These findings demonstrate that participation is a non-random phenotype that is influenced by rare variants, and that individuals who engage in optional UKBB components are not representative of the broader cohort. We show how participation bias can reduce the power of rare variant association studies, potentially masking true associations. This bias should therefore be carefully considered when interpreting results derived from phenotypes with substantial missingness.
ER -